A Cryoinjury Model to Study Myocardial Infarction in the Mouse
September 19th, 2019
9.2K views
This article demonstrates a model to study cardiac remodeling after myocardial cryoinjury in mice.
Overview
This article demonstrates a model to study cardiac remodeling after myocardial cryoinjury in mice. This method is reliable for investigating cardiac recovery, particularly after interventions like stem cell transplantation.
Key Study Components
Area of Science
- Cardiology
- Regenerative Medicine
- Animal Models
Background
- Myocardial cryoinjury is a method to induce heart damage in a controlled manner.
- This model allows for uniform infarct sizes, facilitating reproducibility.
- It serves as a platform for testing novel experimental interventions.
- Results can be validated in larger animal models.
Purpose of Study
- To create a reliable model for studying myocardial infarction.
- To investigate cardiac recovery mechanisms.
- To evaluate the effects of various therapeutic strategies.
Methods Used
- Induction of myocardial cryoinjury in mice.
- Use of anesthetics to ensure humane treatment.
- Preparation of the animal by fur removal and skin disinfection.
- Monitoring of physiological responses during the procedure.
Main Results
- The model successfully generates uniform infarct sizes.
- It allows for the testing of pharmacological and tissue-engineered strategies.
- Responses to interventions can be reliably measured.
- Findings can be extrapolated to larger animal studies.
Conclusions
- This model is effective for studying cardiac remodeling.
- It provides a foundation for future research in cardiac recovery.
- Potential for application in clinical research settings.
Frequently Asked Questions
What is myocardial cryoinjury?
Myocardial cryoinjury is a technique used to induce controlled heart damage for research purposes.
How does this model benefit cardiac research?
It allows for uniform infarct sizes and reproducibility, making it easier to test new therapies.
Can this model be used for large animal studies?
Yes, results from this model can be validated in larger animal models.
What are the main advantages of this method?
The method is quick, easy, and reproducible, allowing for consistent results.
What types of interventions can be tested?
Pharmacological treatments and tissue-engineered strategies can be evaluated using this model.
Is this method humane for the animals used?
Yes, the procedure involves anesthetics to minimize pain and distress.
Executive Industry Relevance
The murine cryoinjury model enables highly reproducible induction of myocardial infarction, supporting rigorous evaluation of cardiac recovery and therapeutic interventions. Its precision in generating uniform infarct sizes addresses a key challenge in preclinical cardiovascular research, enhancing predictive confidence for translational studies. This model is strategically positioned for early-stage validation of regenerative and pharmacological strategies targeting acute coronary syndromes.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables controlled interrogation of cardiac injury and repair mechanisms in vivo.
- Supports functional target validation for regenerative and pharmacological interventions.
- Facilitates mechanistic de-risking by providing consistent injury parameters.
- Improves predictive confidence for downstream translational studies.
Screening & Assay Development
- Provides a standardized platform for evaluating candidate therapies in a reproducible disease-relevant system.
- Enables quantitative assessment of ventricular function and remodeling via echocardiography and histology.
- Supports assay development for functional and structural cardiac endpoints.
- Allows for reliable comparison of intervention efficacy across cohorts.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints such as fibrosis, cardiomyocyte loss, and functional impairment.
- Facilitates continuity from discovery through preclinical validation of cardiac therapies.
- Enables risk-adjusted advancement decisions based on robust, reproducible data.
- Supports translational biomarker development through quantitative readouts.
Pipeline & Workflow Integration
This cryoinjury model integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies with translational validation of cardiac interventions.
- Discovery Biology: Provides a platform for hypothesis testing and pathway clarification in cardiac injury and repair.
- Screening: Delivers reproducible, quantitative outputs for functional and structural cardiac endpoints.
- Analytics: Enables measurement of infarct size, ventricular function, and electrical conduction for comparative analysis.
- Translational Research: Supports alignment with clinical endpoints and facilitates preclinical continuity.
- Enterprise Reuse: Offers a scalable, standardized model for repeated use across therapeutic programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cardiac target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of preclinical cardiac studies.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of cardiac therapeutic candidates.
Implementation Considerations
- Requires expertise in murine surgical techniques and cardiac physiology.
- Demands access to echocardiography, optical mapping, and histological analysis infrastructure.
- Necessitates strict standardization of cryoprobe application to ensure reproducibility.
- Adaptation to other animal models may require protocol optimization.
- Contact duration and probe handling are critical for consistent infarct size.
Biopharma FAQs
Why does null hypothesis testing matter for infarct size quantification?
Null hypothesis testing enables objective evaluation of intervention effects on infarct size, supporting robust target validation and minimizing false positives in cardiac recovery studies.
How does independent variable isolation improve cryoinjury model discovery?
Isolating variables such as cryoprobe contact duration ensures that observed outcomes are attributable to the intervention, increasing confidence in mechanistic insights and discovery-stage findings.
What do quantitative ventricular function measurements enable in this model?
Quantitative measurements like ejection fraction and stroke volume provide actionable endpoints for comparing therapeutic efficacy and guiding advancement decisions in preclinical cardiac pipelines.
Why are replication requirements critical for cross-functional cardiac studies?
Replication ensures that findings are reproducible across teams and studies, facilitating cross-functional collaboration and supporting enterprise-wide confidence in model outputs.
Which statistical analysis capabilities are required before implementing infarct quantification?
Robust statistical analysis is needed to compare infarct sizes and functional outcomes, ensuring that observed differences are significant and supporting data-driven portfolio decisions.
